share_log

Marpai | S-1: General form for registration of securities under the Securities Act of 1933

Marpai | S-1: General form for registration of securities under the Securities Act of 1933

Marpai | S-1：證券上市註冊聲明
美股SEC公告 ·  05/31 05:12
牛牛AI助理已提取核心訊息
Marpai, Inc., a Delaware-based healthcare technology company, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 30, 2024, for a Form S-1 registration. The company, which operates under the ticker symbol MRAI on the OTCQX Market, is preparing for the sale of up to 3,943,334 shares of common stock, which are issuable upon the conversion of certain Senior Secured Convertible Debentures. The sale is set to occur from time to time after the effective date of the registration statement, subject to market conditions. Marpai's common stock was last reported at $0.65 per share on May 29, 2024. The company will not receive any proceeds from the sale of shares by the selling stockholders but will bear the...Show More
Marpai, Inc., a Delaware-based healthcare technology company, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on May 30, 2024, for a Form S-1 registration. The company, which operates under the ticker symbol MRAI on the OTCQX Market, is preparing for the sale of up to 3,943,334 shares of common stock, which are issuable upon the conversion of certain Senior Secured Convertible Debentures. The sale is set to occur from time to time after the effective date of the registration statement, subject to market conditions. Marpai's common stock was last reported at $0.65 per share on May 29, 2024. The company will not receive any proceeds from the sale of shares by the selling stockholders but will bear the expenses of registering these shares. Marpai has recently transitioned from the Nasdaq Capital Market to the OTCQX Market following non-compliance with Nasdaq's minimum stockholders' equity requirement. The company's comprehensive healthcare programs leverage artificial intelligence and data analytics to support self-insured clients in the U.S. The registration statement includes detailed information about the company, the offering, and the associated risk factors.
總部位於特拉華州的醫療保健技術公司Marpai, Inc. 已於2024年5月30日向美國證券交易委員會（SEC）提交了註冊聲明，要求進行S-1表格註冊。該公司在OTCQX市場上以股票代碼MRAI運營，正準備出售多達3,943,334股普通股，這些普通股可在某些優先擔保可轉換債券轉換後發行。銷售將在註冊聲明生效之日後不時進行，但須視市場情況而定。Marpai的普通股最後一次報告爲每股0.65美元，是在2024年5月29日。該公司不會從出售股票的股東出售股票中獲得任何收益，但將承擔註冊這些股票的費用。由於不遵守納斯達克的最低股東權益要求，Marpai最近從納斯達克資本市場過渡到OTCQX市場。該公司的全面醫療保健計劃利用人工智能和數據分析來爲美國的自保客戶提供支持。註冊聲明包括有關公司、產品和相關風險因素的詳細信息。
總部位於特拉華州的醫療保健技術公司Marpai, Inc. 已於2024年5月30日向美國證券交易委員會（SEC）提交了註冊聲明，要求進行S-1表格註冊。該公司在OTCQX市場上以股票代碼MRAI運營，正準備出售多達3,943,334股普通股，這些普通股可在某些優先擔保可轉換債券轉換後發行。銷售將在註冊聲明生效之日後不時進行，但須視市場情況而定。Marpai的普通股最後一次報告爲每股0.65美元，是在2024年5月29日。該公司不會從出售股票的股東出售股票中獲得任何收益，但將承擔註冊這些股票的費用。由於不遵守納斯達克的最低股東權益要求，Marpai最近從納斯達克資本市場過渡到OTCQX市場。該公司的全面醫療保健計劃利用人工智能和數據分析來爲美國的自保客戶提供支持。註冊聲明包括有關公司、產品和相關風險因素的詳細信息。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

獨立文件3  查看翻譯

獨立文件4  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。